Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001204678 | SCV001375895 | uncertain significance | Herpes simplex encephalitis, susceptibility to, 1 | 2022-07-29 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with serine, which is neutral and polar, at codon 50 of the UNC93B1 protein (p.Arg50Ser). This variant is present in population databases (no rsID available, gnomAD 0.09%). This variant has not been reported in the literature in individuals affected with UNC93B1-related conditions. ClinVar contains an entry for this variant (Variation ID: 626042). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Center for Genomics, |
RCV001204678 | SCV003920618 | uncertain significance | Herpes simplex encephalitis, susceptibility to, 1 | 2021-12-22 | criteria provided, single submitter | clinical testing | UNC93B1 NM_030930.3 exon 2 p.Arg50Ser (c.148C>A): This variant has not been reported in the literature but is present in 20/21274 Latino alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs767892224). Evolutionary conservation and computational predictive tools for this variant are unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Ambry Genetics | RCV004027211 | SCV004977928 | uncertain significance | not specified | 2023-12-07 | criteria provided, single submitter | clinical testing | The c.148C>A (p.R50S) alteration is located in exon 2 (coding exon 2) of the UNC93B1 gene. This alteration results from a C to A substitution at nucleotide position 148, causing the arginine (R) at amino acid position 50 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |